1Hinman A R. Global progress in infections disease control[J].Vaccine 1998, 16:1116-1121.
2WolffJ A, Malone R W, Williams P, et al. Direct gene transfer into mouse muscle in vivo[J]. Science 1990, 247:1465-1468.
3Plotkin S L, Plotkin S A.A short history of vaccination[ M]. In:Plotin S A,Plotldn S A, Orenstein W A, ed. Vaccines. 3rd rev ed. Philadelphia:saunders 1999, 1-8.
4Van der Marel P, Hazendank T G, Heneke M A C,et al. Induction of neutralizing antibodies by poliovirus eapsid polypeptides YP1, VP2 and VP3[J]. Vaccine 1983, 1:17-22.
5Tulchinsky T H, l-landsher R, Melnick J L,et al. Immune status to various strains of wild poliovims among children in Gaza immunized with live attenuated oral vaccine alone compaared with combination of live and inactivated vaccines[J]. J Viral Dis 1993, 1:1-9.
6Cohen S, Mendelson I, Altboum Z, et al. Attenuated nontoinogenic and nonencasulated recombinant Bacillus anthracis spore vaccines protect against Athrax [J]. Infect Immun 2000, 68:4549-4558.
7Zhu X, Venkataprasacl N, ]vanyi J, et al. Vaccination with recombinant vaccinia viruses protects mice against Mycobacterium tuberculosis Infection[J]. Immunol 1997, 92:6-9.
8Lowrie D B,Silva C L, Colston M J, et al. Therapy of tuberculosis in mice by DNA vaccination[J]. Nature 1999, 400:269-271.
9Viret J F, Favre D, WegmuUer B, et al. Mucosal and systemic immune responses in humans after primary and booster immunization with orally administered invasive and noninvasive llve attenuated bacteria[J]. Infect Immun 1999, 180:2089-2090.
10Robinson A, Irons L I, Ashworth L A E. Pertussis vaccine:present status and future prospects[J]. Vaccine 1985, 3:11-22.
